RARE
Ultragenyx Pharmaceutical Inc
Price:  
53.66 
USD
Volume:  
910,650.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

RARE Fair Value

-168.84 %
Upside

As of 2024-02-28, the Fair Value of Ultragenyx Pharmaceutical Inc (RARE) is -36.94 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 53.66 USD, the upside of Ultragenyx Pharmaceutical Inc is -168.84%.

Note: valuation result may not be accurate due to the company's negative EPS.

53.66 USD
Stock Price
-36.94 USD
Fair Price
FAIR VALUE CALCULATION

RARE Fair Value

Peter Lynch's formula is:

RARE Fair Value
= Earnings Growth Rate x TTM EPS
RARE Fair Value
= 5.00 x -7.39
RARE Fair Value
= -36.94

The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.

Historical Earnings
2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31 5Y Avg
Net income -402.70 -186.60 -454.00 -707.40 -606.64 -471.47
YoY growth -103.80% 53.66% -143.30% -55.81% 14.24% -47.00%

RARE Fair Value - Key Data

Market Cap (mil) 4,406.02
P/E
Forward P/E
EPS -7.39
Avg earnings growth rate -47.00%
TTM earnings -606.59